1) sulfasalazine (SASP)
柳氮磺胺吡啶(SASP)
2) sulfasalazine
柳氮磺胺吡啶
1.
Apoptosis of hepatic stellate cells induced by sulfasalazine;
柳氮磺胺吡啶诱导HSC-T6肝星状细胞凋亡及其机制
2.
Acute pancreatitis caused by sulfasalazine;
柳氮磺胺吡啶致急性胰腺炎
3.
Clinical effect of jinshuangqi with sulfasalazine for ulcerative colitis;
金双歧联合柳氮磺胺吡啶治疗溃疡性结肠炎疗效观察
3) SASP
柳氮磺胺吡啶
1.
Effect of combine probiotics with SASP on inflammatory bowel disease;
益生菌联合柳氮磺胺吡啶治疗炎症性肠病
2.
Changes of T regulatory cells in rats with experimental colitis after drug treatment with SASP and PSL;
柳氮磺胺吡啶和氢化泼尼松对大鼠结肠炎模型调节性T细胞的影响
3.
They were compered with another 81 cases which were given peroral and retention-enema with SASP.
方法:采用血竭口服及保留灌肠治疗UC患者81例,并与柳氮磺胺吡啶口服及保留灌肠治疗UC患者81例对照。
4) Salazosulfapyridine
柳氮磺胺吡啶
1.
1(CN1,the Pulsatillae decoction) with salazosulfapyridine(SASP) to the ulcerative colitis(UC) model induced by dinitrochlorobenzene (DNCB)-acetic acid(AA) in mice,to research the pathogenesis.
目的:比较中药方灌肠Ⅰ号与西药柳氮磺胺吡啶(SASP)对2,4-二硝基氯苯(DNCB)和乙酸(AA)复合法诱导的小鼠溃疡性结肠炎(UC)模型的治疗效果,并探寻UC发病机制。
5) Sulfasalazine suppository
柳氮磺胺吡啶栓
6) sulfasalazine
柳氮磺吡啶
1.
A method for determination of sulfasalazine based on fluorescence quenching of CdS nanoparticles;
硫化镉纳米粒子荧光淬灭测定柳氮磺吡啶
2.
Determination of residual organic solvents in Sulfasalazine by GC;
柳氮磺吡啶原料药有机溶剂残留溶剂测定
3.
Curative Effect of the Combined Treatment with Sulfasalazine and Medilac-S for Ulcerative Colitis;
柳氮磺吡啶与美常安胶囊联用治疗溃疡性结肠炎临床疗效观察
补充资料：2-磺胺吡啶
分子式：C11H11N3O2S
分子量：249.28
CAS号：144-83-2
性质：黄棕至白色粉末。熔点191-193℃。微溶于水。
制备方法：2-氨基吡啶经缩合、水解而得。
用途：医药中间体。
分子量：249.28
CAS号：144-83-2
性质：黄棕至白色粉末。熔点191-193℃。微溶于水。
制备方法：2-氨基吡啶经缩合、水解而得。
用途：医药中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条